SCHEMBL8247379

SCHEMBL8247379

COc1nc(N)c(Cl)cc1C(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC9A1 P19634 1/20 0.47
▸ HPGD P15428 3/20 0.45
▸ GAA P10253 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ GLA P06280 1/20 0.45
▸ DRD2 P14416 1/20 0.43
▸ CASP1 P29466 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ ROCK1 Q13464 1/20 0.41
▸ POLB P06746 2/20 0.41
▸ NNMT P40261 3/20 0.39
▸ LRRK2 Q5S007 1/20 0.39
▸ NQO2 P16083 1/20 0.39
▸ TSHR P16473 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ HTT P42858 1/20 0.37
▸ NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6331409 0.87 POLB (0.47) SLC9A1HPGDGAAALDH1A1KDM4E
SCHEMBL7395768 0.85 GAA (0.54) SLC9A1HPGDGAAALDH1A1KDM4E
SCHEMBL23797026 0.77 POLB (0.44) SLC9A1HPGDGAAALDH1A1KDM4E
SCHEMBL18669536 0.75 ROCK2 (0.55) HPGDGAAALDH1A1KDM4EGLA
SCHEMBL25300381 0.73 KDM4E (0.53) HPGDGAAALDH1A1KDM4EGLA
SCHEMBL7784015 0.73 CUL4A (0.41) SLC9A1HPGDGAAALDH1A1KDM4E
SCHEMBL8007192 0.73 GSK3A (0.40) HPGDGAAALDH1A1KDM4EDRD2
SCHEMBL6826837 0.72 CASP1 (0.43) HPGDGAAALDH1A1KDM4EGLA
SCHEMBL29361411 0.72 NNMT (0.49) HPGDALDH1A1KDM4ECASP1POLB
SCHEMBL2527039 0.72 NNMT (0.49) HPGDALDH1A1KDM4ECASP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007005951-A2 STEREOISOMERIC PYRIDYL AND PYRIDONYL COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS ARYX THERAPEUTICS, INC. (US) 2007-01-11 — — WO disclosed
Send feedback